DNA polymerase epsilon subunit 3
Also known as: CHRAC17, POLE3
Function
Accessory component of the DNA polymerase epsilon complex. Participates in DNA repair and in chromosomal DNA replication (By similarity). Forms a complex with CHRAC1 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome-remodeling activity of ISWI/SNF2H and ACF1. Does not enhance nucleosome sliding activity of the ACF-5 ISWI chromatin remodeling complex.
Classification
- Family (Pfam)
- PF00808 CBFD_NFYB_HMF
- InterPro
- CBFA_NFYB_domain, DNA_Pol-Epsilon_Subunit, Histone-fold
- Functional cluster
- Protein Serine/Threonine Kinases
Gene Ontology · 17
- GO:0140672 ATAC complex
- GO:0008623 CHRAC
- GO:0008622 epsilon DNA polymerase complex
- GO:0005654 nucleoplasm
- GO:0005634 nucleus
- GO:0031490 chromatin DNA binding
- GO:0003887 DNA-directed DNA polymerase activity
- GO:0046982 protein heterodimerization activity
- GO:0006338 chromatin remodeling
- GO:0006974 DNA damage response
- GO:0006260 DNA replication
- GO:0006261 DNA-templated DNA replication
- GO:0031507 heterochromatin formation
- GO:0006272 leading strand elongation
- GO:0000122 negative regulation of transcription by RNA polymerase II
- GO:0006334 nucleosome assembly
- GO:0006275 regulation of DNA replication
Drugs targeting this protein · 6
- FLUDARABINE PHOSPHATE inhibitor
- GEMCITABINE HYDROCHLORIDE inhibitor
- CLOFARABINE inhibitor
- TROXACITABINE inhibitor
- ASPACYTARABINE inhibitor
- CYTARABINE inhibitor
Related proteins · sequence + function similarity
- DNA polymerase epsilon subunit 3 1.00
- DNA polymerase epsilon subunit 3 1.00
- DNA polymerase epsilon subunit 3 0.99
- DNA polymerase epsilon subunit 3 0.83
- DNA polymerase epsilon subunit D 0.82
- DNA polymerase epsilon subunit D 0.79
- DNA polymerase epsilon subunit D 0.78
- DNA polymerase epsilon subunit D 0.78
- DNA polymerase epsilon subunit 3 0.77
- Transcriptional activator hap3 0.74
- DNA polymerase epsilon subunit D 0.74
- DNA polymerase epsilon subunit D 0.71
Co-cited proteins · studied together in the literature
- Chromatin accessibility complex protein 1 3 shared papers
- DNA polymerase epsilon subunit 4 1 shared papers
- Bromodomain adjacent to zinc finger domain protein 1A 3 shared papers
- SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 3 shared papers
- Bromodomain adjacent to zinc finger domain protein 1A 1 shared papers
- DNA polymerase epsilon subunit 2 1 shared papers
- DNA polymerase epsilon catalytic subunit A 1 shared papers
Literature · 12 cited papers
- System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. · 2011
- Initial characterization of the human central proteome. BMC Syst. Biol. · 2011
- Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. · 2010
- Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem. · 2009
- A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A. · 2008
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. · 2004
- DNA sequence and analysis of human chromosome 9. Nature · 2004
- The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF. Mol. Cell · 2004
- Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. · 2004
- An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin. Nat. Genet. · 2002
- HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins. EMBO J. · 2000
- Identification and cloning of two histone fold motif-containing subunits of HeLa DNA polymerase epsilon. J. Biol. Chem. · 2000
A document in the lmmol reference corpus — open public data (UniProt, GO, PDB, the literature graph) rendered as a single cross-linked page. Hover any link to preview its target.